SCHEMBL8820682

SCHEMBL8820682

CC(=O)C1CCCCN=N1

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28707168 0.78 EPHX1 (0.33) EPHX1
SCHEMBL863279 0.77
SCHEMBL28716310 0.77 EPHX1 (0.34) EPHX1
SCHEMBL31287285 0.77 EPHX1 (0.34) EPHX1
SCHEMBL30719666 0.77 EPHX1 (0.34) EPHX1
SCHEMBL28615639 0.76 POLB (0.38) EPHX1
SCHEMBL8183728 0.73
SCHEMBL28713959 0.72 ALDH1A1 (0.42)
SCHEMBL28703765 0.72 CES2 (0.37)
SCHEMBL16558020 0.70 CTSK (0.47)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1997047623-A1 IMIDAZOLE DERIVATIVES AS PROTECTIVE AGENTS IN REPERFUSION INJURY AND SEVERE INFLAMMATORY RESPONSES CYTOS PHARMACEUTICALS LLC (US) 1997-12-18 WO disclosed
US-5525621-A CARDIOVASCULAR DISORDERS; ANTIINFLAMMATORY AGENTS CYTOS PHARMACEUTICALS LLC (US) 1996-06-11 US disclosed